Gala presents Compás, a ceramic tile range inspired by nature
Compás is a ceramic tile collection with a defined natural inspiration. Both the colors and finishes of Gala’s new range of wall and floor tiles recall nature to offer a versatile and timeless solution that adapts to the different spaces in the home.
The Compás range is a sober line that subtly replicates the typical granulated finish of cement. Soft to the touch and in a satin finish, the range offers a neutral color range, with three available options: white, grey and sand. Moreover, for those projects that search for the extra touch in wall tiles, the collection includes an ornamental model with texture: Suite Compás, with horizontal lines on the surface creating a mesh that recalls a natural fiber tapestry.
For wall tiles, Compás comes in a rectangular 21.4 x 61 cm format, while in floor tiles, the pieces are square (45 x 45 cm) and only available in grey and sand.
Moreover, Compás finds its perfect combination with Mosaico Ligna Roble, a highly original ornamental piece, made up of square tesserae in a wooden finish. The result is a very appealing mosaic, filled with realism (the tesserae fully replicate the veining of wood), which combines perfectly well with all other models of the Compás range.
More information at: gala.es
Gala presents Signo, the new industrial aesthetic ceramic for the home
Gala presents Signo, a complete ceramic collection that masterfully combines industrial aesthetics and the delicacy of neutral tones to dress up all rooms of the home.
Gala, committed to the fight against COVID-19
Gala, a leading manufacturer of bathroom equipment and flat ceramics, is also a company fully committed to society, as it has demonstrated since the beginning of the health crisis caused by COVID-19.
Gala-Innova, the shower toilet that takes personal hygiene to a new level
The toilet that takes personal hygiene and comfort in the bathroom to a new dimension. This is Gala-Innova, the Gala shower toilet.
Gala fights against COVID-19
At Gala we are focusing our efforts on fighting COVID-19.